← Leaderboards
Francisco Sanchez Vega
Sloan-Kettering Inst Can Research
$9,540
Attributed
$28,620
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $383.1K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$745,152 · 2
By mechanism
P20$745,152 · 2
Top collaborators
- T Peter Kingham5 shared
- Olusegun Isaac Alatise2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- T Peter Kingham$2,940,023
- Olusegun Isaac Alatise$2,073,530
- Carol Aghajanian$2,739,199
- Martin S Tallman$1,743,080
- Jennifer Cf Leng$9,013,476
Others in their field
Other Rising Stars on “Colorectal Cancer”
- Joanne Ryan · Hennepin Healthcare Research Institute$4,000,485
- John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc.$3,571,151
- Hailey Rose Banack · State University Of New York At Buffalo$2,634,891
- Daniel Aaron Nelson · Xilis, Inc.$2,397,438
- Johannes Schoeneberg · University Of California, San Diego$2,379,500
- Wantong Yao · University Of Tx Md Anderson Can Ctr$2,140,159
Research focus
Colorectal CancerComplexCollaborationsColon Cancer PatientsAmericanAfricanClinical CareAtlasesBiobankAfrica South Of The SaharaBiological FactorsBiological MarkersBiological Specimen BanksBiologyBlood BanksAdvanced DiseaseCancer CenterCancer Health DisparityCancer ImmunobiologyCancer PatientBiologicalCellsChemotherapyCost
Grant awards (5)
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program$214,919
P20 · FY2025 · CA
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program$87,066
P20 · FY2025 · CA
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program$31,456
P20 · FY2025 · CA
Admin-Core-001$28,620
P20 · FY2025 · CA
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program$383,091
P20 · FY2024 · CA